Over 300 MECP2 mutations and genomic abnormalities have been documented in RTT patients as well as in other mental health disorders, including intellectual disability, autism spectrum disorder, bipolar disorder, and schizophrenia [6]. This evidence concerns the gene MECP2 and autism spectrum disorder.